Emergent BioSolutions Announces Stock Repurchase Program

GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company's common stock on or before March 27, 2026. About Emergent BioSolutions There are a number of important factors that could cause the company's actual results to differ materially from those indicated by such forward-looking statements. Readers should consider this cautionary statement, as well as the risk fa ...